← FDA Drug Approvals (Drugs@FDA)

AXITINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2018-08-07

Drug application

FDA Application #

ANDA210234

Application type

Abbreviated New Drug Application (Generic)

Brand name

AXITINIB

Generic name

Axitinib

Active ingredients

AXITINIB

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

TEVA PHARMS

First approval

2018-08-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown